Adjuvant Anti-VEGF in Vitrectomy for Proliferative Diabetic Retinopathy: Current Evidence, Timing Considerations, and Clinical Implications

Current Ophthalmology Reports · Published 2026-04-28 · DOI 10.1007/s40135-026-00349-w

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1007/s40135-026-00349-w

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Update on the Light-Adjustable Lens (LAL) · Current Ophthalmology Reports · 2022 · Same journal
• Exploring the Unexplored: Targeting MAP4K4 for Glaucoma Treatment · Current Ophthalmology Reports · 2025 · Same journal
• Reaching the Unreachable: Recent Advances and Challenges in Microneedles for Minimally Invasive Ocular Drug Delivery · Current Ophthalmology Reports · 2026 · Same journal
• Update on Factors Contributing to Traumatic Glaucoma Following Ocular Contusion and Globe Perforation · Current Ophthalmology Reports · 2024 · Same journal
• Phakic Lenses in Corneal Ectasia · Current Ophthalmology Reports · 2023 · Same journal
• Management of Surgically-Induced Necrotizing Scleritis: Case Series and Review of the Literature · Current Ophthalmology Reports · 2023 · Same journal
• Pulsatile Flow Disturbances and Region-Specific Microvascular Biomarkers in Glaucoma · Current Ophthalmology Reports · 2026 · Same journal
• Pregnancy and Ocular Health: Physiological Changes and Pathological Challenges · Current Ophthalmology Reports · 2025 · Same journal
• Artificial Intelligence in Ophthalmic Screening: Advancing Diabetic Retinopathy Detection in Low-Income Immigrant Populations · Current Ophthalmology Reports · 2025 · Same journal
• Medication Induced Glaucoma · Current Ophthalmology Reports · 2023 · Same journal